Speakers Lecture

Prof. Howard Maibach | Vebleo | University of California, San Francisco, United States | #1

Presentation Title: In vitro human percutaneous penetration: Clinical and research relevance for pharmacology and toxicology

Prof. Howard Maibach Presented this talk in the webinar on Nanomedicine, Nanomaterials and Nanotechnology organized by Vebleo

Affiliation: MD. Dermatology Department, University California Medical School, San Francisco. Ca. 94143, USA

Biography

Prof. Howard Maibach from UCSF is arguably one of the most famous dermatologists in the world today. Prof. Howard Maibach is an American dermatologist, professor of Dermatology at the University of California, San Francisco. Dr. Howard Maibach is a dermatologist with expertise in treating contact dermatitis (a rash caused by touching an irritating substance) and occupational dermatitis (a rash resulting from workplace exposure to an irritating substance).

He has written over 3,000 research articles, which according to an estimate could be a world record.

Maibach has served on the editorial boards of more than 30 scientific journals. He is a member of 19 professional societies, including the American Academy of Dermatology, San Francisco Dermatological Society and International Commission on Occupational Health.

He has trained in excess of 100 PhD candidates, medical students, postdocs, and fellows. Prof. Howard Maibach is a Research associate at Cancer Research Institute (since 1967); Vice Chairperson at Dermatology (since 1973); Academic Vice Chancellor at Ad Hoc Peer Review Committee (since 1983) and Chief at Occupational Dermatology Clinic, UCSF (since 1984).

Abstract

A generation ago-practical ramifications of nano chemistry captivated many- and skin. Too became involved as a possibly relevant application- for pharmacological applications- and possible toxicological implications.

The presentation will place in biologics context the tools-including strengths and limitations-that belatedly allow us to focus more clearly-on their potential clinical applications, as well as refining our toxicological evaluations.

This talk was delivered in the webinar organized by Vebleo